Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept

Ítems similars

• Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept
  per: Rudwaleit, M, et al.
  Publicat: (2005)
• Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
  per: Baraliakos, X, et al.
  Publicat: (2005)
• Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor alpha antibody infliximab
  per: Baraliakos, X, et al.
  Publicat: (2005)
• Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks
  per: Davis, J, et al.
  Publicat: (2005)
• Two-year follow-up results after re-administration of etanercept in active ankylosing spondylitis
  per: Baraliakos, X, et al.
  Publicat: (2005)